SCG2
Basic information
Region (hg38): 2:223596939-223602361
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 29 | 0 | 1 |
Variants in SCG2
This is a list of pathogenic ClinVar variants found in the SCG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-223597489-G-A | Benign (Apr 10, 2018) | |||
2-223597553-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
2-223597613-T-A | not specified | Uncertain significance (Feb 11, 2022) | ||
2-223597644-T-C | not specified | Uncertain significance (Nov 21, 2023) | ||
2-223597659-G-T | not specified | Uncertain significance (Jun 13, 2024) | ||
2-223597769-C-A | not specified | Uncertain significance (Oct 26, 2021) | ||
2-223597788-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
2-223597813-T-A | not specified | Uncertain significance (Nov 10, 2022) | ||
2-223597892-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
2-223597952-C-T | not specified | Likely benign (Apr 20, 2024) | ||
2-223598001-G-T | not specified | Uncertain significance (Mar 21, 2023) | ||
2-223598034-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
2-223598063-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
2-223598104-G-C | not specified | Uncertain significance (Jan 31, 2024) | ||
2-223598136-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
2-223598171-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
2-223598185-A-C | not specified | Uncertain significance (Dec 28, 2023) | ||
2-223598229-T-C | not specified | Uncertain significance (Nov 28, 2023) | ||
2-223598305-T-G | not specified | Uncertain significance (May 23, 2024) | ||
2-223598336-C-G | not specified | Uncertain significance (Jul 26, 2021) | ||
2-223598349-C-A | not specified | Uncertain significance (Feb 12, 2024) | ||
2-223598351-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
2-223598473-C-A | not specified | Uncertain significance (Jun 27, 2022) | ||
2-223598492-T-C | not specified | Uncertain significance (Apr 28, 2023) | ||
2-223598577-C-T | not specified | Uncertain significance (Dec 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SCG2 | protein_coding | protein_coding | ENST00000305409 | 1 | 5564 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000212 | 0.978 | 125723 | 0 | 24 | 125747 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0751 | 320 | 316 | 1.01 | 0.0000162 | 4123 |
Missense in Polyphen | 87 | 98.881 | 0.87985 | 1370 | ||
Synonymous | -0.529 | 126 | 119 | 1.06 | 0.00000636 | 1112 |
Loss of Function | 2.07 | 11 | 21.3 | 0.516 | 0.00000110 | 279 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000476 | 0.000475 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Secretogranin-2 is a neuroendocrine secretory granule protein, which is the precursor for biologically active peptides.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.423
Intolerance Scores
- loftool
- 0.349
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.76
Haploinsufficiency Scores
- pHI
- 0.839
- hipred
- Y
- hipred_score
- 0.553
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Scg2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;angiogenesis;negative regulation of endothelial cell proliferation;positive regulation of endothelial cell proliferation;inflammatory response;protein secretion;regulation of signaling receptor activity;intracellular signal transduction;endothelial cell migration;post-translational protein modification;cellular protein metabolic process;eosinophil chemotaxis;positive chemotaxis;induction of positive chemotaxis;negative regulation of endothelial cell apoptotic process;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- extracellular space;endoplasmic reticulum lumen;secretory granule;neuronal dense core vesicle
- Molecular function
- cytokine activity;protein binding;chemoattractant activity